Tag: Carillon
Cardiac Dimensions closes funding round to support US EMPOWER pivotal study
Cardiac Dimensions has closed a US$35 million Series D financing round. The financing was co-led...
TCT 2018: Sham-controlled trial indicates indirect annuloplasty reduces mitral regurgitation
REDUCE-FMR indicates that indirect annuloplasty with the Carillon device (Cardiac Dimensions) is...
First patient enrolled in CARILLON pivotal trial
Cardiac Dimensions has announced the company has randomised its first patient in the CARILLON pivota...
Cardiac Dimensions appoints Matthew Stark as vice president of Clinical and Regulatory Affairs
Cardiac Dimensions has appointed Matthew Stark as vice president of clinical and regulatory affairs,...
FDA grant Cardiac Dimensions investigational device exemption approval to conduct study
Cardiac Dimensions has received FDA approval for its investigational device exemption (IDE) CARILLON...
